Ginkgo biloba versus placebo for schizophrenia

Hongyong Deng, Ji Xu, Wing Fai Yeung

Research output: Journal article publicationJournal articleAcademic researchpeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of Ginkgo biloba (or its extractions) for people with schizophrenia or related disorders compared with placebo for outcomes of clinical importance.
Original languageEnglish
Article numberCD012524
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number1
DOIs
Publication statusPublished - 22 Jan 2017

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this